期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (5)
Gynecological malignancies are a leading cause of mortality among females worldwide, and difficulties in early diagnosis and acquired drug resistance ......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (4)
Approximately 15-20% of breast carcinomas exhibit human epidermal growth factor receptor (HER2) protein overexpression. HER2-positive breast cancer (B......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (5)
Bladder cancer (BC) cells exhibit a high basal level of autophagy activity, which contributes to the development of a protective mechanism for cellula......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 63 (5)
Cancer stem cells (CSCs) constitute a specific subset of cells found within tumors that are responsible for initiating, advancing and resisting tradit......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (1)
Prostate cancer (PCa) is one of the most fundamental causes of cancer-related mortality and morbidity among males. However, the underlying mechanisms ......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 63 (4)
MicroRNAs (miRNAs) are non-coding RNAs (ncRNAs) that can post-transcriptionally suppress targeted genes. Dysregulated miRNAs are associated with a var......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 63 (6)
Cancer-associated fibroblasts (CAFs) are pivotal in tumor progression. TP53-deficiency in cancer cells is associated with robust stromal activation. T......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (1)
The present study aimed to explore the role of histone chaperone anti-silencing function 1B (ASF1B) in pancreatic cancer and the underlying mechanism.......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (3)
The worldwide COVID-19 pandemic was brought on by a new coronavirus (SARS Cov-2). A marker/receptor called Dipeptidyl peptidase 4/CD26(DPP4/CD26) may ......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (4)
Photodynamic therapy (PDT) is an effective and low-invasive tumour therapy. However, it can induce tumour angiogenesis, which is a main factor leading......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (5)
The gene encoding the tumor suppressor p53 is the most frequently mutated gene in cancers. However, p53 mutation is rare in acute myeloid leukemia (AM......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 63 (2)
Despite advances in diagnosis and treatment, gastric cancer (GC) remains a refractory disease, which limits overall survival. Therefore, it is key to ......
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 63 (3)
Although checkpoint inhibitors (CPI) have recently extended the treatment options and improved clinical response of advanced stage head and neck squam......